Metrion Biosciences and International Scientific Consortium Publish Data and New Recommendations for in Vitro Risk Assessment of the Cardiac Safety of…

CAMBRIDGE, England--(BUSINESS WIRE)-- Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced it has contributed to two new peer-reviewed papers under the U.S. Food and Drug Administrations (FDA) CiPA (Comprehensive in vitro Proarrhythmia Assay) initiative

Read more
Symtomax: the science behind producing high quality medical cannabis – Health Europa

Indeed, such research has enabled consumers to look beyond the assumption that all forms of cannabis will make them high an assumption attributed to tetrahydrocannabinol (THC), the psychoactive compound within the cannabis plant. Now, non-psychoactive compounds such as Cannabidiol (CBD) are starting to enter consumer markets in a variety of products such as vapes, edibles, and dietary supplements. However, the cannabis plant (Cannabis Sativa), has not solely been used for recreational purposes.

Read more
Leukapheresis Market Is Booming Worldwide | Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc. -…

The Leukapheresis market research report is required to show a gigantic development inside the upcoming years. The investigators likewise have dissected downsides with on-going Organic Semiconductor patterns and in this manner the open doors that are giving to the expanded development of the business. The report gives the viewpoint of this aggressive scene of worldwide markets.

Read more
Experimental drug APN01 prevents COVID-19 infection in the lab – News-Medical.Net

With the world gripped with the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a frantic rush to find an effective drug that can be used to treat the disease. Researchers from the University of British Columbia, in collaboration with others, have found an experimental drug that can inhibit the SARS-CoV-2 virus from infecting host cells. Their study titled, "Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2," was published in the latest issue of the journal Cell.

Read more
Celularity and Infectious Disease Research Institute will try out COVID-19 cell therapy – GeekWire

Celularitys subsidiary, LifebankUSA, maintains a repository of placental and cord blood, containing stem cells for potential therapeutic use. (LifebankUSA / Robert Hariri via Twitter) Seattles Infectious Disease Research Institute and a New Jersey company called Celularity have been cleared by the Food and Drug Administration to start trials of an experimental cell-based therapy for COVID-19

Read more
Orgenesis partners with Belgium"s RevaTis to develop stem cells for therapeutic use – Proactive Investors USA & Canada

The two firms plan to leverage Orgenesiss autologous Cell and Gene Therapy Biotech Platform to produce muscle-derived mesenchymal stem cells (mdMSC) as a source of exosomes Inc () is teaming up with regenerative medicine and cell therapy firm RevaTis on a new joint venture to produce certain stem cells for therapeutic use, it said Wednesday.

Read more